Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 09 Jul 2026 for Spruce Biosciences, INC., €1,056.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Javier B. Szwarcberg: trading record in brief
All filings by Javier B. Szwarcberg on record concern Spruce Biosciences, Inc. The record holds 22 filings, for trades running from 30 December 2022 to 30 June 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 9 July 2026, the filings show a share grant worth €1,056 in Spruce Biosciences, Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Javier B. Szwarcberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
266 shares@ US$4.53050.0009% mcap3.3% of flowCommon StockSEC:0001903669-26-000006:0
1,480 shares0Common StockSEC:0001903669-25-000010:0
1,196 shares0Common StockSEC:0001903669-25-000006:0
4,784 shares0Common StockSEC:0001903669-25-000003:0
358,800 shares0Common StockSEC:0001415889-24-029999:0
111,000 shares0Common StockSEC:0001209191-23-059053:0
20,000 shares@ US$0.977558.3% of flowCommon StockSEC:0001209191-23-041260:0
14,705 shares@ US$0.932841.7% of flowCommon StockSEC:0001209191-23-002152:0
8 of 8 declarations
